What is Polychromasia on a Peripheral Blood Smear?
Polychromasia refers to the presence of red blood cells that appear blue-gray or purple-tinged on a Wright-stained peripheral blood smear, representing young reticulocytes (immature red blood cells) that still contain residual RNA.
Cellular Basis and Appearance
Polychromatophilic erythrocytes are essentially young reticulocytes visualized on routine Wright-Giemsa stained blood smears 1. These cells retain residual ribosomal RNA and other organelles, which stain with the blue component of the Wright stain, creating their characteristic blue-gray or polychromatic appearance mixed with the pink hemoglobin 2.
- The blue-gray color results from the basophilic staining properties of residual RNA
- These cells appear larger than mature RBCs
- They lack the central pallor typical of mature erythrocytes
Clinical Significance
Polychromasia indicates active erythropoiesis and bone marrow response to anemia or blood loss 2. The presence and degree of polychromasia provides important diagnostic information:
When Polychromasia is Present:
- Suggests appropriate bone marrow response to anemia, hemolysis, or blood loss
- Correlates with elevated reticulocyte counts
- Indicates accelerated red cell production
Relationship to Reticulocytes:
Polychromatophilic cells on Wright-stained smears correspond to the youngest reticulocytes (Heilmeyer groups I and II), which are not normally found in peripheral circulation 2. These "shift reticulocytes" represent the most immature forms released from the marrow in response to erythropoietin stimulation.
Diagnostic Context
When evaluating peripheral blood smears, polychromasia should be assessed alongside other morphological features 3:
- Degree of polychromasia helps assess marrow response adequacy
- Absence of polychromasia in an anemic patient suggests inadequate marrow response or maturation defects
- Must be interpreted with RBC indices (MCV, MCH, MCHW) and reticulocyte count
Common Clinical Scenarios:
- Hemolytic anemias: Prominent polychromasia expected 4
- Acute blood loss: Polychromasia appears 3-5 days post-hemorrhage
- Response to treatment: Iron, B12, or folate therapy
- Bone marrow disorders: Absence suggests marrow failure or infiltration
Important Caveats
The assessment of polychromasia has limitations:
- Subjective evaluation: Requires experienced microscopist
- Stain quality dependent: Variations in Wright stain batches affect visualization 1
- Semi-quantitative: Reported as slight, moderate, or marked
- Should correlate with reticulocyte count: Discordance requires investigation 2
In conditions like pyruvate kinase deficiency, reticulocytosis may be present but not proportional to hemolysis severity, as younger cells are preferentially sequestered by the spleen 5.